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ABSTRACT 
Self-regulation i s  a major characterist ic pertaining t o  in vivo blood 
coagulation. 
geneous in space. 
blood flow in vivo. Because of this inhomogeneity, the chemical rate equa- 
tions should be modified by fluid-dynamic (or flow-dilution) change and diffu- 
sion change. This report  proposes a simple model of enzyme reactions and 
emphasizes the flow-dilution change of the reactions. Firs t ,  the complex 
reactions in blood coagulation a r e  discussed and weighed. Second, two con- 
trolling chemical reactions, the prothrombin-to-thrombin conversion and the 
inactivation of thrombin, both of which have significant positive and negative 
feedbacks, a r e  selected. It is seen then, that the reaction rates  of both these 
reactions will decrease a s  thrombin concentration is decreased by flow dilu- 
tion. But the positive rate decreases more  (because of the autocatalyzation of 
the prothrombin-thrombin conversion) than the negative rate. 
flow dilution increases,  the overall reaction direction can be switched from 
the positive (procoagulative) direction t o  the negative (anticoagulative) direc- 
tion; thus the in vivo coagulation i s  regulated and confined. 
picture i s  analytically investigated by solving the modified Michaelis-Menton's 
enzyme rate  equations. 
i s  a lso investigated. 
ext ens ively d i s cus s ed. 
In vivo coagulation i s  a set  of enzyme reactions that a r e  inhomo- 
The inhomogeneity i s  maintained by the dilution of the 
Therefore when 
This physical 
The effect of varying the antithrombin concentration 
The background and the physics of this analysis a r e  
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I. INTRODUCTION 
Blood coagulation is a very complex 
phenomenon. It involves more  than a dozen com- 
plex enzyme reactions. 
initiated by various mechanisms, for example, by 
contact with a foreign surface, by contact with 
mater ia ls  from broken tissues, broken blood 
cells. o r  broken platelets, by imbalance of 
plasma factors, and by unknown defects in the c i r -  
culating system. Many texts (Refs. 1 - 5 )  and 
thousands of papers (Ref. 6 )  on the subject of 
blood coagulation have been published since the 
last century. In the las t  twenty years ,  however, 
a major portion of the l i terature  in this field has 
been devoted to  the identification of enzyme reac-  
tions involved in blood coagulation in  \ itro. 
[Ferguson recently published a long rtview ar t ic le  
on this, which includes 250 references (Ref. 7).] 
F r o m  these in vi t ro  studies, at least  two major 
theories have been proposed t o  date t o  explain the 
enzyme reactions in the blood coagulation process. 
One is the cascade theory (Ref. 8) o r  thewaterfall 
theory (Ref. 9 ) ,  which is represented in the 
following diagram: 


















l a  
1- 
All the Roman numbers here  a r e  the international 
symbols for  the preactivated and activated (with 
subscript a )  plasma factors: I1 is  the prothrom- 
bin, 11, is the  thrombin, I is the fibrinogen, I, is 
the fibrin. In this diagram, the product of every 
reaction s tep is assumed to  be the catalyst for the 
next step. This theory does not show the inacti- 
vating mechanism of thrombin and the autocata- 
lyzing effect of the prothrombin-to-thrombin 
reaction. Also, c ross  (or feedback) paths of 
many reactions a r e  not indicated in the cascade. 
The second major theory was proposed by 
Seegers (Ref. IO). He proposed a set of more 
complicated enzyme pathways as shown in Fig.  1 .  
It includes some feedback reactions, but the 
weight (probability) of each pathway is not fully 
discus sed. 
F r o m  the above short sketch, it is seen that 
the theories actually propose different se t s  of 
chemical pathways that the enzymes in the blood 
will follow when coagulation proceeds. The influ- 
ence of blood flow on chemical kinetics is not 
discussed in these theories. In general, extensive 
analytical studies seem to occupy only a smal l  
portion of the contemporary literature of blood 
coagulation (Refs. 1 1  and 12). Particularly, t o  
the author's knowledge, the self-regulatory phe- 
nomenon of in vivo blood coagulation has hardly 
been explored analytically. , 
Self-regulation of blood coagulation in vivo is 
familiar to  us as a phenomenon. 
referred to  as the ability of maintaining blood flu- 
idity in vivo (Ref. 13).] As we know, without anti- 
coagulant, the blood coagulates easily in vitro. 
The coagulation, once initiated, will spread to the 
whole volume of the blood. But, in a healthy man, 
in vivo coagulation does not spread easily through 
his circulating system even i f  the coagulation is 
initiated by the same agent (e. g., contact with 
[It is a lso 
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foreign surface) in vitro and in vivo. 
there  must be some self-regulatory mechanism in 
vivo that i s  not effective in vitro. To the author's 
knowledge, t he re  a r e  at least two recognized fac- 
t o r s  that might account for the difference between 
these two cases of coagulation. 
Clearly, 
The f i rs t  i s  the flow dilution effect, which is 
operative when clotting i s  initiated on the wall of 
a vessel  that i s  not completely severed. 
activated enzymes in the in vivo blood will be 
diluted by circulating blood all the time. As 
explained later, these diluted enzymes (proco- 
agulants) will eventually give way to  the anti- 
coagulants that normally exist with constant 
concentrations in the blood. Therefore, the 
coagulation, once initiated, will eventually be 
confined in the in vivo flowing blood. This 
dilution control of the in vivo coagulation has 
been mentioned in a general way by MacFarlane- 
Smith (Ref. 14), Burton (Ref. 15), and Waugh 
(Ref. 16). 
The 
The second factof concerns the functions 
of the blood vessels. F o r  example, nine dif- 
ferent kinds of blood vessels have been found 
t o  have anticoagulants in their walls (Ref. 17). 
These anticoagulants do not exist in blood in 
vitro. But in vivo, it i s  doubtful that they exert 
a major effect since it has been shown that the 
blood can sti l l  coagulate easily (without regula- 
tion) in isolated venous segments (Ref. 18). On 
the other hand, the flow dilution effect seems t o  
be commonly recognized a s  the regulatory 
mechanism although it has not been analytically 
examined. 
This report  discusses a kinetic model of 
blood coagulation that takes the flow dilution effect 
into account. It is a model of modified Michaelis- 
Menton's enzyme kinetics applied to  blood 
coagulation. 
The l i terature of the kinetics of clotting 
enzymes can be divided into two groups. 
f i rs t  group is the major one that deals with the in 
vitro identification and rate  determination of 
enzyme pathways in blood coagulation. 
second group reports more  analytical results,  for 
example, calculations of reaction constants, in 
vitro studies of the variations of clotting t ime with 
respect to  enzyme concentrations, and investiga- 
tions of the kinetics of some simplified chain 
reactions (Refs. 19-39) .  'In general, however, it 
i s  to  be noted that most of the papers in the 
second group do not take into account the physical 
differences between the in vivo and in vitro states 
of the blood. F o r  example, most analyses follow 
from the Michaelis-Menton' s model, which, with- 
out modification, i s  a kinetic model for stationary 
and homogeneous enzyme reactions only. This is 
not the case for the in vivo coagulation reactions 
that a r e  both nonstationary (flowing) and inhomo- 
geneous. Also, most analyses do not include a 
complete transient-asymptotic solution of the rate  
equations. The complete transient-asymptotic 
solution i s  necessary for studying the buildup and 
confinement of in vivo coagulation. In contrast t o  
all these investigations, the goal of this report  i s  
to  present the physical complexity involved in the 
in vivo case and to draw a much simplified model 
from it such that it can be shown analytically that 
the flow dilution alone i s  sufficient t o  explain the 
self-regulatory phenomenon of in vivo coagulation. 
The 
The 
'One may think that chemical reactions may take place across  the vessel  wall such that the anticoagula- 
tion feedback may come f rom outside the vessel  wall by permeating the enzyme molecules through the 
wall. But this is very unlikely, because the permeating rate  should be much too slow t o  match the pro- 
coagulation reactions happening inside the wall. 
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11. THE MODEL 
Three major assumptions of the present 
model a r e  discussed in detail in this section. 
A. Assumption 1: A Modified Michaelis- 
Menton's Model of Enzyme Reactions Is 
Assumed 
Michaelis -Menton's model of enzyme reaction 
is a homogeneous, two-stage chemical reaction as 
shown in the following: 
(1) 
k l  kg 
k2 
S t E t  I - P t E  
where S, E, I, P represent, respectively, the 
molecules of substrate, enzyme, intermediate, 
and product. In this model, it is assumed that the 
concentration of the intermediate I reaches a 
steady state very fast as compared with other 
changes in the reaction. That is, 
- -  ;; - 0 
is assumed valid during the main course of the 
reaction. With this  assumption, the rate of pro- 
ducing P can thus be derived, in t e r m s  of the rate  
constants and the initial concentrations, in a much 
simplified way. However, when this model i s  
applied to  in vivo coagulation reactions a modifi- 
cation must be added to the ra te  equations; this 
modification is the flow dilution effect of the acti- 
vated enzymes. The mechanism and modeling of 
this flow dilution effect will be discussed in 
As sumption 3. 
B. Assumption 2: The Main Controlling Steps in 
the Chemical Reactions of Coagulation Are  
the Prothrombin- t o - T hrombin ( P- T ) C onver - 
sion and the Inactivation of Thrombin T by 
Antithrombin A. 
The P-T conversion is the s tep that immedi- 
ately proceeds the fibrinogen-to-fibrin (F-fn) 
reaction, which is the final chemical event in  
forming a clot. 
sion, i. e . ,  T, is the activating enzyme for the 
F-fn reaction. 
reactions leading t o  clot formation, only P-T con- 
version and the inactivation of T have appreciable 
positive and negative feedback mechanisms. The 
positive feedback is due to  the autocatalysis of the 
P-T reaction. That is, T is a n  enzyme that can 
accelerate  the P -T  reaction. Therefore, the 
more  T produced, the faster the acceleration of 
the P-T reaction. The negative feedback is due to  
the function of antithrombin A normally existing in 
the plasma. When T is produced, A will react  
with it and tu rn  it back t o  the inactivated form. 
That is, A can destroy the active T and conse- 
quently slow down the coagulation. 
The product of the  P -T  conver- 
It appears that among a l l  the 
Next, we shall investigate the relation 
between the variation of T and the clot forming 
criterion. 
sidered as consisting of three steps (Ref. 40). 
F i r s t ,  F f t R, where f i s  the fibrin monomer 
and R is a residual. Second, m f-fm, where fm 
is a partially polymerized molecule. 
n fm-fn, where fn is  the completely polymerized 
clot. 
consumed chemically during the reaction (adsorp- 
tion of T by the clot will be discussed shortly); 
yet without T, the F-fn reaction will stop immedi- 
ately because a l l  the three  steps in the reaction 
a r e  not autocatalyzed reactions. Therefore, to  
complete the polymerization of the clot, a certain 
amount of T must be present long enough to  pro- 
duce a concentration of fibrin monomers suffi- 
cient for polymerization. If the concentration of 
T at a flowing point appears only in a very short 
period of time, then, except for some isolated fm 
molecules possibly formed, the clot will not be 
formed at that point. These fm molecules will be 
diluted in the blood s t ream and fibrinolyzed later 
by protamine. Consequently, a criterion for  a 
point in the blood flowing closely by an in vivo 
clot t o  coagulate and t o  join the clot is  the 
following: 
The F-fn reaction usually is con- 
Finally, 
T is an  enzyme in the first s tep and is not 
The quantity 
B E dt (footnote 2)  
for that flowing point must be greater  
than a cr i t ical  value C. Here T is the 
thrombin concentration at that flowing 
point and T is the t ime required for 
that point t o  flow by the clot surface. (3) 
When B at a flowing point under consideration is 
grea te r  than C, there  exists enough T in a certain 
amount of t ime or there  exists a certain amount 
of T in  an enough time for  complete polymeriza- 
tion at that point when it passes by the in vivo clot 
surface. Therefore, that point will clot and stick 
to  the clot surface. Consequently, the in vivo clot 
grows. 
On the other hand, when B is smaller than C, 
Therefore, 
that point will not complete the polymerization 
during its course flowing by the clot. 
that point, even if it polymerizes later, will not 
stick t o  the clot. Thus, the in vivo clot is 
confined. 
Now we shal l  discuss the reactions before the 
P-T reaction and those after the clot is formed. 
The reactions before the P-T reaction have no 
appreciable feedback mechanism. If any of these 
2Loosely speaking, B is the "product" of the thrombin concentration and the effective reaction time for 
a point flowing by the clot just formed. 
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reactions i s  initiated by any means, it will 
converge t o  the P - T  reaction before the clot i s  
formed. Therefore, even i f  all the enzymes at 
some point a r e  activated but the P -T  reaction i s  
st i l l  confined by some mechanism (e.g., by 
injecting antithrombin into the vessel)  a clot s t i l l  
will not be formed, and all  the activated enzymes 
will be proteolyzed later in the blood stream. 
For  the reactions after the clot i s  formed, there  
a lso i s  no important controlling effects t o  the clot, 
because once the clot i s  formed, it cannot be 
destroyed by immediately next reactions. 
example, the adsorption of T by a fibrin clot can 
take place only after the polymerization i s  com- 
pleted, while the confinement of the clot i s  deter-  
mined [according t o  Relation (3)] before the 
completion of the polymerization. Therefore, 
the adsorption of T by the clot will not have sig- 
nificant feedback effect on forming the clot. 
Another reaction after clotting is fibrinolysis. 
This i s  a proteolytic process that dissolves the 
clot by means of proteolytic enzymes. Its rate 
should be very slow t o  give any immediate effects 
after the clot is  formed. 
For  
The use of T in F-fn reaction will also affect 
the rates  of the two controlling reactions. But its 
effect should be small. The reason i s  the follow- 
ing: T is  a catalyzer in the F-fn reaction; the 
lifetime of the intermediate formed by a catalyst 
molecule and a substrate molecule i s  usually very 
short, i. e . ,  the intermediate will usually 
decompose to  a product molecule and a catalyst 
molecule very fast. Therefore, to a f i rs t  approxi- 
mation, the decreasing of "free" T concentration 
due t o  the engagement of T molecules in the cata- 
lyzation of the F-fn reaction can be neglected a s  
compared t o  the creating rate  and destroying rate 
of T due to  both controlling reactions. 
Finally, the platelet also plays an important 
role in the blood coagulation process by initiating 
the chain reactions there,  and by accelerating the 
P- T reaction without appreciable feedback effect 
(Refs. 41 and 42). In this report ,  the effects of 
platelets and other nonfeedback procoagulants 
such as Ac-globulin, vitamin K, and calcium ions 
a r e  assumed as par t  of the reaction constant of 
the P-T reaction. 
G. Assumption 3: A Much Simplified Dilution 
Model Is Assumed 
In vivo coagulation i s  a set  of inhomogeneous 
chemical reactions affected significantly by dilu- 
tion effect. "Inhomogeneous" here means that the 
concentrations of reactants and products a r e  not 
homogeneous in space, and initiation mechanisms 
a r e  not homogeneously introduced t o  the blood. 
For  in vitro experiments, the homogeneity can be 
reached in a short t ime either by self-diffusion of 
molecules o r  by shaking the test  tube. But for in 
vivo blood coagulation, the homogeneity can hardly 
be reached during the whole course of reactions 
because of the constant dilution3 of the activated 
enzymes due to continuous wash of the flowing 
blood. 
the chemical changes should vary  from "point"- 
to-"point" in space. 
ally means a macroscopic "point", not a 
geometrical point. 
geneous medium. 
that chemical concentrations inside can be con- 
s id e red hom ogeneous ly distributed in s pace all 
the t ime, but large enough s o  that the chemical 
reactions inside will not get down t o  molecular 
scale with large inhomogeneity in space. This 
sphere i s  tentatively called the "sphere of homo- 
geneity". In the following, whenever the phrase 
I I a  (flowing) point" is  mentioned, it means actu- 
ally "a (flowing) sphere of homogeneity". 
inhomogeneous stationary fluid, this sphere i s  
stationary in space, and the rate equation of any 
chemical reaction inside the sphere would be 
modified only by a diffusion change a s  a result  of 
the inhomogeneity. For  an inhomogeneous flowing 
fluid, however, the sphere of homogeneity moves 
with the macroscopic particle velocity of the fluid, 
because chemical reactions in the fluid a r e  
"following-the-particle" (in the sense of fluid- 
dynamic t e rms)  or "following-the-point" 
reactions. Fo r  this flowing fluid, additional cor- 
rections due t o  flow dilution must be made for the 
rate equations. Strictly speaking, the form of 
these flow dilution t e rms  should be determined by 
the statistical fluid mechanics of the fluid. This, 
however, would certainly make the rate  equations 
excessively complicated t o  solve a s  well as t o  
formulate without much gain in physical implica- 
tions. Therefore, in this report, it i s  assumed 
only that the flow dilution will give an additional 
change of the concentration of a certain newly 
produced chemical (e.g., thrombin) at a flowing 
point according t o  the following relation: 
Fo r  an inhomogeneous chemical reaction, 
The word "point" here  actu- 
It i s  a sphere in the inhomo- 
This sphere is small  enough so 
F o r  an 
= -IYM (4) aM (%) due to flow dilution 
where M i s  the concentration of the newly 
produced chemical in mole/liter and the propor- 
tionality constant IY has the following property: 
CY i s  an increasing function of the 
inhomogeneity (e. g., the gradient of the 
velocity) at the flowing point and IY i s  
zero when the fluid is stationary. (5) 
Relation (4) means that the more  the molecules 
aggregate at a point, the more  the molecules will 
be washed away pe r  unit t ime by the flow dilution, 
while Relation (5) is  just a result  of the fact 
that the larger  the inhomogeneity, the larger  the 
rate  of flow dilution, and no flow dilution can 
occur when the fluid i s  stationary. Usually IY 
should increase as the clot grows in vivo. Fo r  
example, if  an in vivo clot grows in a large 
vessel, the velocity of the clot is always zero, 
while the velocity of the blood increases from 
ze ro  near the vessel  wall to  a maximum on the 
axis of the vessel. Therefore, the dilution effect 
should grow larger  and larger when the clot grows 
deeper and deeper into the blood s t ream of a large 
31t is  to  be noted that the dilution effect here i s  to  be distinguished from the dilution of the plasma 
mentioned in many in vitro experiments in the l i terature (Refs. 19-36). 
dilution of a l l  molecules by adding water o r  other solvents t o  the plasma, while the former  is an  
inhomogeneous dilution of the activated molecules only by flowing blood. 
The latter i s  a homogeneous 
4Section V has more  discussion on this model of the dilution effects. 
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vessel. Fo r  stationary blood, the pure diffusion 
dilution is responsible for spreading the coagula- 
tion. But for flowing blood, the pure diffusion 
dilution should be negligible as compared with the 
flow dilution. Therefore, in the following formu- 
lation of in vivo coagulation, pure diffusion effect 
is neglected, and only Relation (4) is added t o  the 
"following-the-point" chemical ra te  equations. 
Next, we shal l  discuss the effect of flow 
dilution on prothrombin concent ration. Prothr  om- 
bin P is an  enzyme normally existing in the blood 
with constant concentration. When it participates 
in the P-T reaction taking place locally at the 
perturbed region, its concentration will decrease 
locally there. But the blood flow tends to  mix the 
perturbed blood with the unperturbed blood so as  
to  keep the P concentration in the perturbed 
region normal. Therefore, the effect of blood 
flow on the prothrombin that normally exists in 
the blood is a "refilling" increase of the concen- 
tration in contrast to  the dilution decrease of the 
concentrations for  those enzymes not normally 
existing in the blood. 
Finally, we shall discuss  the initial condition 
for the blood flow model assumed here. 
When the coagulation proceeds in vivo, 
the thrombin molecules will diffuse from the clot 
already formed and mix immediately with the 
blood flowing by. 
thrombin molecules by a flowing point in the 
blood is a very complicated phenomenon. 
continuous process in time and space, and it 
depends very much on the path of the flowing 
point. Its exact behavior, again, should be 
determined by fluid dynamics and diffusion 
mechanics. But t o  a f i r s t  approximation, we 
can assume that any flowing point entering the 
perturbed region will take up an amount of throm- 
bin that has an  initial concentration TO. If there  
were no chemical reactions and no flow dilution, 
this T O  would be constant along its path flowing 
by the clot. 
reactions a r e  taken into account as analyzed in 
Section 111, this TO i s  then the initial concentra- 
tion of T taken up by a flowing point entering the 
perturbed region. 
this point will then vary according to  the analysis 
given in Section 111. 
The "taking-up" of these 
It is a 
But when flow dilution and chemical 
The concentration of T at 
With these three  assumptions of the model in 
mind, we a r e  going t o  formulate the chemical ra te  
equations and t o  solve them in the next section. 
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111. RATE EQUATIONS AND SOLUTION 
Following the Michaelis -Menton' s mod e 1, 
Reaction ( l ) ,  we can write the enzyme reactions 
of the controlling steps taking place at a flowing 
point as: 
k l  k3 
k2 
P + T c' 1 - 2 T (positive feedback) (6) 
k4 k6 
T t A Q - A + P (negative f e e d b a ~ k ) ~  (7 )  
k5 
where P ,  T, A, I, Q are ,  respectively, the 
molecules of prothrombin, thrombin, antithrom- 
bin, and intermediates. The "following-the- 
point" ra te  equations of the chemicals involved in 
the above reactions are: 
- _ -  dT  klPT + (kz + 2 k3) I - k4AT + k5Q - aT 
dt 
= klPT - (kz + k3) I - a1 
dt (9)  
All T, P, I, Q, A molecules are now concentra- 
tions expressed in mole/liter. 
these equations a r e  the flow dilution t e rms  given 
by Equation (4); a has the property given by 
Relation (5). The rate  equations of other chemi- 
cals a r e  not used in  the following calculation 
because of Michaelis-Menton's assumption. 
The las t  t e r m s  in 
Now the conservation of mass  will be con- 
sidered. If the lifetimes of the intermediates I 
and Q in Reactions (6) and (7)  a r e  quite short (this 
is the usual case for  enzyme reactions), if T is 
not occupied by F x f n  reaction too long as  dis-  
cussed in Assumption 2, and if the dilution effect 
on T is  compensated by the "refilling" effect on P 
(see Assumption 3), then we should have, for a l l  
the time, 
P + T  = P = constant (11) 0 
Finally, the initial condition of the 
reactions a t  a flowing point under consideration 
as discussed a t  the end of Assumption 3 i s  
T = To a t t  = 0 (12)  
At this point, the mathematical formulation 
is complete and we can solve the  problem as 
follows. 
Applying Equation ( Z ) ,  we see  that 
dI/dt = dQ/dt = 0. 
from Equations (9) and (10) algebraically. 
stituting Q and I into Equation (8) and eliminating 
P by Equation ( l l) ,  we have 
Thus Q and I can be solved 
Sub- 
where 
The general  solution of Equation (13) with the 
initial condition of Equation (12) is easily obtained 
as 
T =  
T 
To - +  - + e t  1 - y e  
However, the variations of the T-t  curves with 
respect t o  the changes of a and A (or the flow 
dilution ra te  and the antithrombin concentration) 
a r e  quite complicated. The study of these var i -  
ations and the i r  significances a r e  discussed in 
the next section and Appendices A and B. 
51f the negative "feedback" reaction is T t A-X instead of Reaction (7), then the mathematics should be 
modified but the result and the physical consequences should not change because the destroying ra te  of 
T from the new reaction is s t i l l  linearly proportional to  T. Therefore, the dilution decrease of T will 
s t i l l  have less  effect on this new negative reaction than on the posifive (autocatalytic) Reaction (6). 
Consequently, the  procoagulation tendency can still be switched to  the anticoagulation tendency when 
dilution rate increases .  The reason that Reaction (7) is proposed here  is that there  must be a re turn 
path for  T to P, otherwise the in vivo blood is not in a stable state - any small ignition will change P 
permanently. 
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IV. ANALYSIS AND INTERPRETATION O F  THE RESULT 
The variations of the T-t curves with respect 
t o  LY and A a r e  studied analytically in  Appendices 
A and B, respectively. The result follows. 
A. The Variation of the T-t  Curves with Respect 
to  LY or the Flow Dilution Rate 
When A in the blood is kept at a constant con- 
centration Ao, this variation is shown in Fig. 2. 
Several  points a r e  t o  be noted here. 
Each of these curves will approach an  
asymptotic level T, monotonically when 
t approaches infinity, and 
+(CY) is a function of a. given by 
Equation (14). It is  a monotonically 
decreasing function of CY. &b shown in 
the figure is the root of the equation 
$(CY) = 0. The curve with e =  Ob is the  
boundary curve between the curves with 
T, f 0 and with T, = 0. 
The steepness of the curve will increase 
(or the slope will decrease)  a s  a. 
increases. Theoretically, when CY 
increases  to  infinity, the transient 
thrombin concentration will be a step- 
down function in t ime a s  shown. 
Now we can see  that no matter how large 
T is, t he re  is always a curve with C Y =  
such that the  relation B = C [B is the 
quantity defined in Relation (3)] can be  
satisfied. F o r  the curves below this 
curve ( C Y  >  CY^), B < C and for those 
above this  curve (CY < oc), B > C. The 
reason for  this is that B decreases with 
CY when T i s  fixed and B approaches ze ro  
when LY approaches infinity. (Integration 
of a stepdown function as shown in Fig. 2 
a s  o--m is always zero). Therefore, i f  
the flow dilution can be increased indefi- 
nitely, there  always exists a cr i t ical  flow 
dilution ra te   CY^ such that beyond which no 
clotting is possible. 
A comparison between the curves in 
Fig. 2 (for which both dilution and chem- 
ica l  reactions a r e  in action) and the 
curves due t o  flow dilution alone has the 
following properties: for small  dilution 
rates  (a. small), the decreasing ra te  of T 
due to both mechanisms is slower than 
that due t o  dilution alone; for  large dilu- 
tion rates (a. large), the situation 
reverses .  
follows. 
According t o  Assumption 3 and 
Equation (4), the ra te  of change of T at 
a flowing point due t o  dilution alone will 
The proof of this statement 
be dT/dt = -aT. 
equation is 
The solution of this 
It i s  seen that T always approaches zero 
when t approaches infinity. The 
decreasing rate  of T in Equation (17) is 
la rger  than that of the curves in Fig. 2 
when CY is small, because the latter will 
not approach ze ro  and some of them may 
even "increase" with respect to  time. 
Fo r  large CY, then, a s  shown in 
Appendix C, the solution of T due to both 
mechanisms can be approximated by 
where 
e < o , + > o  
and, f rom Equation (14), 
This le$l is  l a rger  than a. 
when a. is large, T in Equation (18) 
decreases fas ter  than that due t o  dilution 
alone (Equation 17). QED. 
Therefore, 
B. The Variation of the T-t Curves with Respect 
t o  A or the Antithrombin Concentration 
This will be quite s imilar  to  that when CY is 
varied. Schematically, i f  all the e's  in Fig. 2 
a r e  replaced by A, we then obtain a set  of T-t  
curves with A as the running parameter. 
quently, we see that, for a fixed LY, there  a l so  
exists a fixed antithrombin concentration, A,, 
such that when A > A,, no clot will be formed at 
the flowing point under consideration, and when 
A < A,, clot will be established there. 
C. 
Conse- 
The Case Where T,-, = 0 
When TO = 0, from Equation (15), T will be 
F r o m  the properties discussed in Subsections 
equal to zero  all the time. 
A, B, and C, some important physical conse- 
quences can be drawn immediately. 
(1) No matter whether the blood is flowing 
o r  stationary, the blood cannot clot by 
itself without some thrombin present o r  
produced in the blood. This follows f rom 
the statement in Subsection C. 
means, some thrombin is produced in the 
bIood, then the coagulation may take place, ' 
may spread indefinitely, o r  may be 
If by any 
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confined locally, depending on the situa- 
tion of the blood. 
(2) A clot can easily develop in a stationary 
blood (a = 01, but not in a flowing blood 
(a f 0). 
point in a stationary blood,due to  any 
activating mechanism introduced to that 
point, or  due to  the a r r iva l  of the throm- 
bin molecules diffusing from the adjacent 
points, that point will clot and the clot 
will spread by diffusion of the residual 
thrombin molecules. This i s  because 
the a = 0 curve in Fig. 2 is above the 
critical curve with a = oc, therefore, 
the clot will develop. On the other hand, 
when blood i s  flowing in a vessel, the 
more the clot grows in the flowing blood 
the more the dilution will be as  discussed 
in Assumption 3 .  Above a cr i t ical  dilu- 
tion ra te  (a 2 ac), the blood flowing by 
the clot will stop clotting because B will 
be smaller  than C when a 2 ace. There-  
fore, by Relation ( 3 ) ,  these points will 
not clot and thus the clot is confined. 
Thrombin molecules a r e  produced o r  
destroyed (inactivated) chemically (not 
just diluted) depending on whether the 
flow dilution is small  or large. 
proved for low dilution ra te  in point (3 )  
of subsection A of this Section, the actual 
If thrombin i s  present at any 
( 3 )  
As 
decreasing ra te  of T (Fig. 2) is slower 
than that due to  dilution alone; for high 
dilution rate, the situation reverses .  
Therefore, thrombin molecules a r e  actu- 
ally produced at the flowing point under 
consideration when the dilution there  i s  
small, and destroyed when the dilution i s  
large. This can be seen more directly 
f rom the two major chemical reactions 
listed in relations (6) and (7). 
prothrombin-thrombin reaction i s  an 
autocatalyzed reaction. Loosely speak- 
ing, the producing rate  of T due to this 
reaction i s  proportional to the square of 
T (thrombin concentration). On the 
other hand, the A-T reaction (inactiva- 
tion of thrombin) i s  not an autocatalyzed 
reaction. Generally, the destroying 
(inactivating) ra te  of T i s  proportional 
t o  T only. Therefore, the loss of T due 
t o  dilution will cause the producing rate  
to  decrease more  than the destroying 
rate. Consequently, the reaction direc-  
tion i s  switched from producing T to 
destroying T when flow dilution 
increases. 
The 
(4) If antithrombin i s  added to  the blood, the 
effect will be similar t o  that of increas-  
ing the dilution rate. 
immediately from subsection B of this 
Sect ion. 
This follows 
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V. DISCUSSION 
A. Dilution Effect on the In Vitro Flow 
The in vi t ro  flow dilution must be a real 
dilution t o  allow the self-regulation phenomenon 
to  occur. 
Some in vitro flowing-blood experiments have 
shown artificial thrombosis or  the fast clotting 
effect (without self-regulation) (Refs. 43-51). 
This seems to be a violation of the principalresult 
described in this report. But a careful study of 
these experiments shows that the activating sur -  
faces in these experiments a r e  so large that the 
activated enzymes a r e  almost everywhere. Con- 
sequently not much dilution effect can be expected 
even where the blood flows rapidly in these sys-  
tems. Among these experimental investigations, 
Dentinfass' reports  on the viscometer experi- 
ments a r e  particularly interesting. 
Dentinfass (Refs. 45-51) has done a ser ies  of 
in vitro experiments showing that the larger  the 
shearing rate  of the blood flow in vitro, the 
shorter  the clotting time. This, a t  a f irst  glance, 
seems to  be a contradiction of what this  report 
proposes. However, a careful examination of his 
experimental procedures and apparatus reveals 
that there  a r e  many differences between his in 
vitro system and the in vivo system. F i rs t ,  the 
blood in his  experiments i s  put between two 
coaxial cones of a viscometer with the outer one 
rotated at a controlled speed. 
the cones a r e  not specially treated with anticoagu- 
lants. They a r e  the foreign activating surfaces to  
the blood. Therefore, when the blood rotates a s  
the outer cone rotates, not much dilution effect 
can be expected since every circumferential point 
on the path of the blood movement i s  equally acti- 
vated. Second, the rotation s ta r t s  a t  zero veloc- 
ity, and, at the beginning, the blood cells a r e  
distributed uniformly in the c ross  section of the 
flow. Therefore, the blood cells in the boundary 
layer will be subject t o  large shearing s t resses  a s  
rotating speed increases. It i s  very likely that 
many blood cells a r e  broken during the starting 
period of the experiments. 
(Ref. 52) done at  Berkeley records that the larger  
the rotation speed of the viscometer, the la rger  
the hemolysis found in the blood; this report 
strongly supports this suggestion. On the other 
hand, for large-vessel in vivo flow (a  non- 
Newtonian flow), the blood cells flow with almost 
uniform speeds and concentrate along the axial 
portion of the vessel. A plasma sheath flowing 
outside the blood cel l  column will buffer between 
the vessel  wall and the blood cells. Therefore, 
the blood cells flowing in large vessels  should 
suffer very little shearing s t r e s s  and broken 
damage (Refs. 53 and 54). For  smal Ivesse1  
(capillary) flow, the blood cells a r e  bent and 
squeezed through the vessel  with low speed 
(0.4 mm/s  in capillary), but they a r e  not subject 
t o  large shearing s t r e s s  either (Refs. 54 and 55). 
It i s  the shearing s t r e s s  that breaks the blood 
cells. Following these discussions, it is seen 
that Dentinfass' experiments actually have many 
basic differences from the in vivo systems. 
The surfaces of 
A recent experiment 
B. Differences Between In Vivo and In Vitro 
Coaeulations 
The exact factors causing the differences 
between the in vivo coagulation and the in vitro 
coagulation should be carefully differentiated. 
The factor of vessel  functions has been dis- 
The factor of cussed and weighted in Section I. 
flow dilution i s  analyzed in this report. 
there  is another factor that appears, at a f i rs t  
glance, t o  be responsible for the difference 
between the two cases of coagulation. 
sampling activation of the blood. 
vivo blood i s  sampled through sampling devices, 
it may be activated already. 
look like the major cause responsible for the dif- 
ference between the two cases of coagulation. A 
ph-positive baby subject t o  total transfusion after 
birth can sti l l  grow normally (without significant 
thrombosis), although the blood is transfused to  
his body through an apparatus that may have the 
same effect a s  the sampling devices just men- 
tioned (Ref. 56). Therefore, sampling activation 
cannot be the major factor that makes in vitro 
blood clot more easily than in vivo blood. 
Now 
This is the 
When the in 
But this does not 
C. Modification of the Dilution Model, 
Equation (4) 
The present model assumes that the dilution 
effect is expressed by 
aA = -crM (Equation 4) a t  
Actually the flow dilution i s  a very complicated 
phenomenon. It i s  a combination of the mechan- 
i sms  of diffusion, convection, and turbulence. A 
part of these mechanisms is studied in the fields 
of chemical transport process and chemical 
hydrodynamics (Refs. 57-59). It appears that 
most of the investigators assume that the dilution 
due t o  convection-diffusion takes the form of 
where 
velocity of the particle, and J is the particle f h x  
due to  convection-diffusion. The last equality is 
valid for incompressible fluid only. On the other 
hand, the dilution due t o  turbulence-diffusion i s  
assumed to  be 
is the statistically ayeraged s t ream 
where Dt is  a function of the statistical behavior 
of the eddies in the  turbulence. With this new 
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model of dilution and neglecting the V and V2 
t e rms  for the intermediates I and Q, we will have 
a modified following-the-particle ra te  equation 
for the thrombin concentration T: 
where f(T)  E e ( +  - T )  T is the chemical ra te  
function given by Equation (13). i; and Dt a r e  
determined by solving the statistical fluid- 
dynamic problem encountered. This equation is 
a nonlinear partial differential equation in  space 
and time. It is very difficult to solve under any 
realizable boundary and initial conditio s. Never- 
nonlinear fluid dynamics may be promising in 
application because to a f i r s t  approximation the 
theless, the Method of Characteristics t used in 
coefficients of the equation do not depend on the 
independent variables. 
It i s  the author's opinion that this  new 
dilution model may be more  accurate than the 
model assumed in this report. However, in spite 
of the difficulty of solving Equation (21). the 
physical effect of this new model on the chemical 
reactions should be the same as that described in 
Section IV because the overall effect of the dilu- 
tion in the new model is still a decrease of the 
product concentration (TI. This decrease will 
again switch the reaction direction a s  explained 
in point 3 of Section IV. Therefore, not too 
many physical implications can be expected f rom 
this new model. Nevertheless, for  an accurate 
quantitative prediction of the cr i t ical  regulation 
of in vivo flowing blood, a continuous model 
like the one given in Equation (21) should be 
applied. 
'Method of Characteristics is a standard method used to  solve some nonlinear partial differential 
equations in hydrodynamics. 
Refs. 60 and 61. 
Examples of the texts dealing with this method a r e  given in 
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VI. CONCLUSION 
This report emphasizes the physical effects, coagulation. Yet, under these simplified 
particularly, the flow dilution effect, on the assumptions, it i s  shown rigorously in this report  
chemical kinetics of blood coagulation in vivo. 
The assumptions a r e  over simplified relative 
t o  the extremely complicated picture of in vivo vivo coagulation. 
that flow dilution alone can be the factor respon- 
sible for the self-regulatory phenomenon of in 
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Seegers’ theory of blood clotting (simplified diagram) 
A = A. = NORMAL ANTITHROMBIN 
CONCENTRATION IN PLASMA 
I 
i 
a z ac-’ B < C 
a = a  - B = C  
< Qc’ 6 > c 
TO 
Tm 
= *(a) # 0 ! 
Fig. 2.  Variation of thrombin concentration with 
respect to flow dilution rate 
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APPENDIX A 
VARIATIONS OF T-t CURVES [REPRESENTED BY EQUATION (15) IN THE TEXT] 
WITH RESPECT TO CY OR THE FLOW DILUTION RATE 
Firs t ,  we shall  study the variation of T-t  
curves with respect  to e and 9. This can be done 
either by studying the differential Equation (13) or  
i ts  solution, Equation (15), in the text. The 
resul t  is shown in Fig. A-1. 
the denominator of Equation (15) vanishgs]. These 
cases are  not physically realizable. However, as 
seen in the following, they will never happen for 
any real values of CY and A, i. e., no real CY and A 
values will f i t  all the conditions shown above the 
sketches of case 3-1 and case 5. 
Cases 3-1 and 5 have poles a t  t = t [where 
Next, we shall  study the variation of 8, 4 with 
respect to cy. Rewriting 8 and + [Equation (14)] in 
the following, 
(A-1) 
we see  that 8 decreases  monotonically as (Y 
increases,  but decreases  monotonically until 
0 -0, then + switches f rom - m  to +m and keeps 
"positive" when CY increases  further. 
plying the two expressions in Equation (A-l) ,  we 
see  that e+ a lso  decreases  monotonically as LY 
increases.  Moreover, the asymptotic values of 
Also multi- 
e, +, and ell, as CY approaches infinity a r e  the 
following: 
lim + e =  lim - LY = - m  
o--m LY-co 
Therefore the curves of 9, 8, e+ vs CY mus t  look 
like that as shown in Fig. A-2. 
The last  line in the above figure shows the 
corresponding cases of Fig. A-1 as LY increases.  
Finally, we want to prove that the slope of a 
T-t curve a t  a fixed T level decreases  monotoni- 
cally as  CY increases;  i. e. ,  the larger  the flow 
dilution rate ,  the steeper the T-t curve. This 
can be shown easily f rom the differential Equa- 
tion (13): when T is fixed, the e+ (Fig. A-2) 
decreases  as  the (Y increases,  hence the less  the 
slope TI. Also as shown in Appendix C, when 
(Y- m, the T-t  curve should approach a stepdown 
function in time. 
F r o m  a l l  the above analyses, we obtain 
immediately the schematic curves shown in 
Fig. 2 in the text. 
1 6  JPL Technical Memorandum 33-490 
CASE 1. WHEN To = 0, T = 0 ALL THE TIME 
CASE2. S>O, 9 > 0  
CASE2-3: ' = T  CASE 2-1 : 9 < To CASE 2-2: 0 > To Top-=-' T O I L  
t t t 
CASE 3. e c 0, 9 > o 
0 CASE 3-2: ' >To CASE3-3: 9 =  T CASE 3-1: 9 < To 
ToL 
CASE 4. e > 0, 9 4 o 
CASE 5. 9 c 0, 9 c 0 
CASE 6. 9 = 0, 9 f 0, 
FROM EQUATION (151, T' = -e? AND 1 - 1 = et 
T To 
CASE 7. 9 = 0, '-a, BUT 99 = - K, K IS A POSITIVE CONSTANT. FROM EGUATION (13), 
T' = - KT - T = T 
0 









Fig. A-2. Variation of $, 9, $0 with respect to 
flow dilution rate 
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APPENDM B 
VARIATIONS OF T-t CURVES WITH RESPECT TO A 
With the result  of Fig. A-1 in Appendix A, we 
need now to study only the variations of 8, + with 
respect to A when CY i s  fixed. F r o m  Equation 
(A-1), we see that 8 i s  not a function of A, and 
that + i s  a monotonically, linearly decreasing 
function of A i f  8 i s  positive (i. e., i f  (Y < k3), and 
a monotonically, linearly increasing function of A 
i f  8 i s  negative. These variations a r e  shown in 
Figs. B-1 and B-2, respectively. The last lines 
in both figures show the corresponding cases  in 
Fig. A-1 when A increases. It i s  seen that 
the variations due to increasing A should be 
about the same  a s  that due to increasing a. 
Similarly, we can prove directly from Equa- 
tion (13) that the steepness of the T-t  curve 
increases (or  slope decreases) a s  A increases. 
The schematic drawing of the T-t curves when 
A varies is omitted here because it is similar 
to Fig. 2 in the text i f  all a ' s  a r e  replaced by 
A's. 
CASES: 2-2 2-3 2-1 6 4 
Fig. B-1. Variation of +wi th  respect to 
antithrombin concentration a t  
low flow dilution 
Tot I 
AO 
CORRESPONDING CASE 3-2 
Fig. 8 - 2 .  Variation of + with respect to 
antithrombin concentration a t  
high flow dilution 
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APPENDIX C 
ASYMPTOTIC T(t) FUNCTION WHEN CY IS LARGE 
When CY >> k3, we see from Fig. A-2 that Jc 
will  increase to +a. Therefore, Jc >> To when CY is relation is equivalent to 
large,  and in the general  solution of T, i. e., in 
Equation (15), we can neglect TO as compared 
with +. Consequently, we have, 
Since + > 0 and e < 0 when CY > kg, this 
-le91 t T = T o e  
T T~ ee+ 
when 
CY >> k3 
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